TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34994269

Group type: EXPERIMENTAL
Intervention: Triple Pill (telmisartan 20 mg, amlodipine 2.5 mg, indapamide 1.25 mg)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Triple Pill
Number of subjects: 1500
Study: 34088582

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 90
Study: 36165681

Group type: EXPERIMENTAL
Intervention: Intralesional HBV vaccine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramuscular HBV vaccine
Number of subjects: 60
Study: 33351153

Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 30
Study: 35265233

Group type: EXPERIMENTAL
Intervention: Percutaneous kyphoplasty (PKP) combined with calcitriol and calcium
Number of subjects: 36

Group type: COMPARATOR
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 36
Study: 32123315

Group type: EXPERIMENTAL
Intervention: Phenelzine 30 mg orally twice daily
Number of subjects: 20
Study: 32511226

Group type: EXPERIMENTAL
Intervention: IDA (Ivermectin, Diethylcarbamazine, and Albendazole)
Number of subjects: 5761

Group type: COMPARATOR
Intervention: DA (Diethylcarbamazine and Albendazole)
Number of subjects: 5761

Group type: EXPERIMENTAL
Intervention: IDA
Number of subjects: 5761

Group type: COMPARATOR
Intervention: DA
Number of subjects: 5761
Study: 34509996

Group type: EXPERIMENTAL
Intervention: Aggressive hydration
Number of subjects: 560

Group type: COMPARATOR
Intervention: General hydration
Number of subjects: 560
Study: 32816255

Group type: EXPERIMENTAL
Intervention: Care navigation strategies
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Individual empowerment and knowledge of treatment benefits
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Interpersonal relationships
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Creative problem solving
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Opportunities for care delivery improvement
Number of subjects: 21
Study: 36138309

Group type: EXPERIMENTAL
Intervention: Foley catheter removal on postoperative day two after negative cystogram
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hospital length of stay
Number of subjects: 24
Study: 34140041

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 37773124

Group type: EXPERIMENTAL
Intervention: Very Brief Advice + Lung Age (VBA + LA)
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Very Brief Advice + Exhaled Carbon Monoxide (VBA + CO)
Number of subjects: 1368

Group type: COMPARATOR
Intervention: Very Brief Advice (VBA)
Number of subjects: 1368
Study: 33566122

Group type: COMPARATOR
Intervention: Omentectomy (group A, control arm)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Omentum preservation (group B, test arm)
Number of subjects: 251
Study: 36193304

Group type: EXPERIMENTAL
Intervention: Chloroform
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Eucalyptol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Orange Oil
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Xylene
Number of subjects: 80
Study: 34533783

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan (early initiation)
Number of subjects: 0
Study: 34390601

Group type: EXPERIMENTAL
Intervention: Angulated screw-retained crowns (AG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cemented crowns (CG)
Number of subjects: 56
Study: 32277258

Group type: EXPERIMENTAL
Intervention: 85-dB music at 8 km/h
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 85-dB music at 10 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: 80-dB music at 8 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: 80-dB music at 10 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: 85-dB music at 12 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: No music at 8 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: No music at 10 km/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: No music at 12 km/h
Number of subjects: 50
Study: 35910068

Group type: EXPERIMENTAL
Intervention: 0.2 μg/kg of sufentanil
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 0.4 μg/kg of sufentanil
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 0.6 μg/kg of sufentanil
Number of subjects: 124

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 124
Study: 32891501

Group type: EXPERIMENTAL
Intervention: Recovery coaching intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 98
Study: 36333766

Group type: EXPERIMENTAL
Intervention: Class 1 (n=400, 66.1% of the cohort)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Class 2 (n=102, 16.9% of the cohort)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Class 3 (n=103, 17% of the cohort)
Number of subjects: 605

Group type: COMPARATOR
Intervention: High PEEP vs. low PEEP (ALVEOLI trial)
Number of subjects: 605

Group type: COMPARATOR
Intervention: Conservative vs. liberal fluid management (FACTT trial)
Number of subjects: 605
Study: 32201443

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg intravenous over 10 min
Number of subjects: 54

Group type: COMPARATOR
Intervention: Midazolam 0.035 mg/kg intravenous over 1 min
Number of subjects: 54
Study: 35582945

Group type: EXPERIMENTAL
Intervention: Client‐centred activities of daily living (CADL) intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: Usual ADL (UADL) intervention
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both CADL and UADL interventions
Number of subjects: 145
Study: 32986904

Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT) - observation of uni/bimanual goal-directed actions followed by execution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control Group (CG) - watched same-duration computer games and then performed the same actions in the same order as EG
Number of subjects: 8
Study: 33306587

Group type: EXPERIMENTAL
Intervention: Kinetic chain (KC) training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional shoulder exercise training (CT)
Number of subjects: 40
Study: 33545483

Group type: EXPERIMENTAL
Intervention: High levels of serum BPA (2.92 ng/mL)
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Low levels of serum BPA
Number of subjects: 1370

Group type: EXPERIMENTAL
Intervention: Baseline eGFR levels
Number of subjects: 1370
Study: 32497906

Group type: EXPERIMENTAL
Intervention: Transradial artery access (TRA)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Transfemoral artery access (TFA)
Number of subjects: 673
Study: 33909150

Group type: EXPERIMENTAL
Intervention: Histopathological characteristics (Tumor-infiltrating lymphocytes - TILs)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: CNN-based TMB-H prediction model
Number of subjects: 201
Study: 32561160

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine (iGlar)
Number of subjects: 0
Study: 36107563

Group type: EXPERIMENTAL
Intervention: 1 L polyethylene glycol/ascorbic acid (PEG/Asc)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Oral sodium sulfate (OSS)
Number of subjects: 172
Study: 33341444

Group type: EXPERIMENTAL
Intervention: FOLFOX + cetuximab
Number of subjects: 5337
Study: 32068423

Group type: EXPERIMENTAL
Intervention: Cognitive AS treatment
Number of subjects: 127

Group type: COMPARATOR
Intervention: Repeated contact control
Number of subjects: 127
Study: 36109825

Group type: EXPERIMENTAL
Intervention: Dexamethasone (6 mg once daily for 7 days)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 252
Study: 33705748

Group type: EXPERIMENTAL
Intervention: EVO100
Number of subjects: 860

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 860
Study: 36246990

Group type: EXPERIMENTAL
Intervention: High-dose Dexmedetomidine
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Medium-dose Dexmedetomidine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-dose Dexmedetomidine
Number of subjects: 102
Study: 34755269

Group type: EXPERIMENTAL
Intervention: Colchicine (1.5 mg at baseline and 0.5 mg BID PO for 10 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 116
Study: 33261611

Group type: EXPERIMENTAL
Intervention: Genetically proxied milk consumption (using genetic variant rs4988235 or rs182549)
Number of subjects: 1000486

Group type: EXPERIMENTAL
Intervention: Genetically proxied milk consumption
Number of subjects: 1000486
Study: 36178956

Group type: EXPERIMENTAL
Intervention: Combined short-axis out-of-plane and long-axis in-plane approach
Number of subjects: 110
Study: 33372371

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intracervical normal saline infiltration
Number of subjects: 100
Study: 32869246

Group type: EXPERIMENTAL
Intervention: Statement of truth before symptom validity tests (SIMS)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Statement of truth after symptom validity tests (SIMS)
Number of subjects: 248
Study: 37355528

Group type: COMPARATOR
Intervention: Standard preoperative education
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Additional module on realistic expectations
Number of subjects: 172
Study: 33264819

Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 34052927

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation (PBM) treatment (pulsed near-infrared 808 nm Ga-Al-As laser, 250 mW, 8.8 J/cm2) for up to 12 weeks in addition to standard care
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study: 33319355

Group type: EXPERIMENTAL
Intervention: Transabdominal and transperineal ultrasound before instrumental vaginal delivery
Number of subjects: 222

Group type: COMPARATOR
Intervention: Routine clinical care (control) before instrumental vaginal delivery
Number of subjects: 222
Study: 33526085

Group type: EXPERIMENTAL
Intervention: Mindfulness Training (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active Control (AC)
Number of subjects: 40
Study: 34865002

Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Treatment arms (not specified)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 188
Study: 33223412

Group type: EXPERIMENTAL
Intervention: Mobile-bearing TKA
Number of subjects: 291

Group type: COMPARATOR
Intervention: Fixed-bearing TKA
Number of subjects: 291
Study: 32819999

Group type: EXPERIMENTAL
Intervention: Comprehensive molecular testing plus routine microbiological testing
Number of subjects: 440

Group type: COMPARATOR
Intervention: Standard diagnosis (only microbiological routine testing)
Number of subjects: 440
Study: 35654025

Group type: EXPERIMENTAL
Intervention: Intravesical gemcitabine + docetaxel (Gem/Doce)
Number of subjects: 60

Group type: COMPARATOR
Intervention: BCG
Number of subjects: 60
Study: 33601334

Group type: EXPERIMENTAL
Intervention: Daily feedback
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Contingent incentives
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combination of daily feedback and contingent incentives
Number of subjects: 57

Group type: COMPARATOR
Intervention: Weekly feedback
Number of subjects: 57

Group type: COMPARATOR
Intervention: Noncontingent incentives
Number of subjects: 57
Study: 32536056

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue recipe
Number of subjects: 207

Group type: COMPARATOR
Intervention: Fuzheng Huayu capsule
Number of subjects: 207
Study: 35138767

Group type: EXPERIMENTAL
Intervention: Endovascular therapy with medical care
Number of subjects: 203

Group type: COMPARATOR
Intervention: Medical care alone
Number of subjects: 203
Study: 33932360

Group type: EXPERIMENTAL
Intervention: Exercise intervention for 12 months
Number of subjects: 134
Study: 35835446

Group type: EXPERIMENTAL
Intervention: Nasal breathing
Number of subjects: 198
Study: 33863614

Group type: EXPERIMENTAL
Intervention: Supervised formal physical therapy (PT)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Self‐directed home exercises
Number of subjects: 147
Study: 36372120

Group type: EXPERIMENTAL
Intervention: Nasal ventilation exercise (NV+PR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Voluntary hypoventilation (vHV+PR)
Number of subjects: 19
Study: 34261995

Group type: EXPERIMENTAL
Intervention: Judo (120-min per week for 3 months)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 44
Study: 35689191

Group type: EXPERIMENTAL
Intervention: Healthy Youngsters, Healthy Dads (HYHD) program
Number of subjects: 125

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 125
Study: 34222141

Group type: EXPERIMENTAL
Intervention: Creative Music Therapy (CMT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 82
Study: 32534250

Group type: EXPERIMENTAL
Intervention: External trigeminal nerve stimulation (ETNS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual medical treatment (Control)
Number of subjects: 40
Study: 35672789

Group type: EXPERIMENTAL
Intervention: Piezocision group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 32748071

Group type: EXPERIMENTAL
Intervention: FOI with tongue root holder
Number of subjects: 300
Study: 33982238

Group type: EXPERIMENTAL
Intervention: AC group (anesthesia consultation group)
Number of subjects: 186

Group type: COMPARATOR
Intervention: POP group (standard postoperative group)
Number of subjects: 186
Study: 34197641

Group type: EXPERIMENTAL
Intervention: Double Foley catheter (DFC)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Cook cervical ripening balloon
Number of subjects: 222

Group type: COMPARATOR
Intervention: Foley catheter (FC)
Number of subjects: 222
Study: 32243994

Group type: EXPERIMENTAL
Intervention: Supervised treatment (exercise, education, diet, insoles, and pain medication)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Written advice
Number of subjects: 100
Study: 36319990

Group type: EXPERIMENTAL
Intervention: Locally tailored preconception care (PCC) intervention with a social marketing strategy
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Locally tailored preconception care (PCC) intervention
Number of subjects: 850
Study: 35053648

Group type: EXPERIMENTAL
Intervention: Hippotherapy combined with Schroth exercises
Number of subjects: 52

Group type: COMPARATOR
Intervention: Schroth exercises alone
Number of subjects: 52
Study: 33977825

Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32131886

Group type: EXPERIMENTAL
Intervention: Personalized acupuncture
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Fixed acupuncture
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Placebo letrozole
Number of subjects: 1100
Study: 34087337

Group type: EXPERIMENTAL
Intervention: Cardiac glycosides (CGs)
Number of subjects: 5311

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation at enrollment
Number of subjects: 5311
Study: 36201753

Group type: EXPERIMENTAL
Intervention: EstroSense®
Number of subjects: 148
Study: 33586476

Group type: EXPERIMENTAL
Intervention: Multidisciplinary, group-based programme using a cognitive-behavioural approach, 6 sessions of 2 hours duration
Number of subjects: 130
Study: 32468719

Group type: EXPERIMENTAL
Intervention: 0.5 mg fingolimod HCl capsule (Lebrina)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 0.5 mg fingolimod capsule (Gilenya)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both formulations of fingolimod
Number of subjects: 33
Study: 35685899

Group type: EXPERIMENTAL
Intervention: basic treatment + electroacupuncture
Number of subjects: 150

Group type: COMPARATOR
Intervention: basic treatment
Number of subjects: 150
Study: 34309987

Group type: EXPERIMENTAL
Intervention: Melissa officinalis tea (MO tea), 2-g dried leaves/250 mL in hot water, two times/day for 12 weeks, in addition to lifestyle modification recommendations.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received lifestyle modification recommendations only.
Number of subjects: 60
Study: 36227682

Group type: EXPERIMENTAL
Intervention: Thoracic epidural block with dezocine and ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 60
Study: 33185582

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study: 33059801

Group type: EXPERIMENTAL
Intervention: Single-dose intramuscular injection of vitamin D3 (10,000 IU/kg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Oral vitamin D3 drops (900 IU/d) for 25 days
Number of subjects: 59
Study: 35583869

Group type: EXPERIMENTAL
Intervention: Lifestyle Coaching (LC)
Number of subjects: 1761

Group type: EXPERIMENTAL
Intervention: Enhanced Pharmacotherapy (EP)
Number of subjects: 1761

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1761
Study: 32697726

Group type: EXPERIMENTAL
Intervention: Fuzzy static output‐feedback controller (SOFC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fuzzy filtering
Number of subjects: 0
Study: 32665410

Group type: EXPERIMENTAL
Intervention: Celebrity webinar
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Celebrity video
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Doctor webinar
Number of subjects: 721

Group type: COMPARATOR
Intervention: Control
Number of subjects: 721
Study: 35394515

Group type: EXPERIMENTAL
Intervention: Gram stain-guided antibiotic therapy
Number of subjects: 206

Group type: COMPARATOR
Intervention: Guideline-based antibiotic therapy
Number of subjects: 206
Study: 33714824

Group type: EXPERIMENTAL
Intervention: Quartz diorite
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rhomb porphyry
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lactose (placebo dust)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quartz diorite, Rhomb porphyry, Lactose
Number of subjects: 24
Study: 32421638

Group type: EXPERIMENTAL
Intervention: Tactile cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speech cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: No cueing (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-modal cue pairings
Number of subjects: 0
Study: 35428577

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste and NovaMin (Sensodyne® Repair and Protect, England)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Fluoride toothpaste (Sensodyne® Rapid Relief, England)
Number of subjects: 38
Study: 32189338

Group type: EXPERIMENTAL
Intervention: Pregabalin 14 mg/kg/d
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Pregabalin 7 mg/kg/d
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 35725421

Group type: EXPERIMENTAL
Intervention: Amandla Mama mHealth videos, short 2D animated health promotional videos that promote healthy behavior in expectant mothers.
Number of subjects: 450
Study: 32189646

Group type: EXPERIMENTAL
Intervention: Elderly persons in old age homes
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Men in old age homes
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Women in old age homes
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Elderly persons aged ≥80 years
Number of subjects: 334
Study: 34649262

Group type: EXPERIMENTAL
Intervention: α‐lactalbumin (A‐LAC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (whey protein)
Number of subjects: 16
Study: 36233538

Group type: EXPERIMENTAL
Intervention: Hochuekkito (TJ‐41) treatment combined with pulmonary rehabilitation (PR) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (low-intensity exercise without TJ‐41 treatment) for 12 weeks
Number of subjects: 0
Study: 35174607

Group type: EXPERIMENTAL
Intervention: Topical fat‐loss lotion containing Coleus forskholii, Silybin, Eucommia ulmoides leaf, Paullinia cupana seed, caffeine, and black pepper essential oil applied twice daily for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo control lotion applied to the same sites on the other leg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical fat‐loss lotion
Number of subjects: 20
Study: 32654917

Group type: EXPERIMENTAL
Intervention: Therapy (not specified in detail)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (healthy patients)
Number of subjects: 30
Study: 35085837

Group type: EXPERIMENTAL
Intervention: LAP-RFA
Number of subjects: 57

Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 57
Study: 32570126

Group type: EXPERIMENTAL
Intervention: Blood patch pleurodesis (100 mL autologous blood injected at days 5 and 6)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Observation (no intervention)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Surgical revision (Group C)
Number of subjects: 24
Study: 34718341

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Supportive Therapy (ST) for 12 weeks
Number of subjects: 72
Study: 33450188

Group type: EXPERIMENTAL
Intervention: Grass-pollen sublingual immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35529454

Group type: EXPERIMENTAL
Intervention: Bilateral continuous theta-burst stimulation (Bi-cTBS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Unilateral intermittent theta-burst stimulation (Uni-iTBS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bilateral intermittent theta-burst stimulation (Bi-iTBS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15